EnWave Signs Research and Development License Agreement with Danish Technological Institute, The Canadian Business Journal4 min read
VANCOUVER, British Columbia, March 16, 2023 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW I FSE:E4U) (“EnWave”, or the “Company”) today announced that it has signed a Research and Development License (the “License”) with the Danish Technological Institute (“DTI”), a leading research and technology company.
DTI will acquire a 10kW Radiant Energy Vacuum (“REV™”) machine to conduct product and process development work with several of their customers. DTI is known for helping their client base convert the newest knowledge and technology into value. The License will allow DTI to produce limited quantities of commercial products for market testing and analysis. EnWave believes that DTI has the network and capabilities to highlight the value proposition of REV™ technology in several industries and looks forward to fruitful collaborative work.
About Danish Technological Institute
Danish Technological Institute is an independent and non-profit research and development institute. Since 1906 the Institute has worked to promote the application of technological advances, for the benefit of both the individual business and the continued development, growth, and prosperity of society as a whole.
DTI delivers 40,000 advanced technological solutions annually in response to concrete needs and challenges of our more than 12,000 customers.
The institute’s work for this purpose is carried out by approximately 1,000 specialists, who – in close cooperation with 800 research and development partners, assist both small and large enterprises to remain competitive and innovative. We provide a solid technological infrastructure built on specialized professional and domain-specific knowledge and world-class equipment.
The Institute delivers technological services that contribute to the required development and conversion in Danish companies. This takes place in line with interdisciplinary and highly relevant societal drivers: digital transformation, green conversion, the circular economy and growth, productivity, and innovation capacity.
For more information regarding DTI, please visit https://www.dti.dk/.
EnWave is a global leader in the innovation and application of vacuum microwave dehydration. From its headquarters in Vancouver, BC, EnWave has developed a robust intellectual property portfolio, perfected its Radiant Energy Vacuum (REV™) technology, and transformed an innovative idea into a proven, consistent, and scalable drying solution for the food, pharmaceutical and cannabis industries that vastly outperforms traditional drying methods in efficiency, capacity, product quality, and cost.
With more than fifty royalty-generating partners spanning twenty countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner, and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.
EnWave’s strategy is to sign royalty-bearing commercial licenses with food and cannabis producers who want to dry better, faster, and more economical than freeze drying, rack drying and air drying, and enjoy the following benefits:
- Food and ingredients companies can produce exciting new products, reach optimal moisture levels up to seven times faster, and improve product taste, texture, color and nutritional value.
- Cannabis producers can dry four to six times faster, retain up to 20% more terpenes and 25% more cannabinoids, and achieve at least a 3-log reduction in crop-destroying microbes.
Mr. Brent Charleton, CFA President and CEO
For further information:
Brent Charleton, CFA, President and CEO at +1 (778) 378-9616
E-mail: [email protected]
Dylan Murray, CFO at +1 (778) 870-0729
E-mail: [email protected]
Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, the Company ceasing to make investments in NutraDried, the timing of the wind-down and dissolution of NutraDried, expectations around the cost of winding down NutraDried, and the Company’s intended focus for the future are forward-looking statements. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended, including that the process of winding up NutraDried will involve time and expense to the Company materially greater than anticipated, that the realization of assets of NutraDried will not sufficiently cover the orderly wind-up of NutraDried, which could result in the requirement for additional funding by the Company to complete such wind-up, that the foregoing developments will adversely affect the Company, in terms of cost, management time and focus, outlook or reputation; the ability of the Company to achieve its longer-term outlook, the ability to lower costs, and the other risk factors set forth in the Company’s public filings. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f0992078-015c-4d05-b53e-c4e5692d431f